An experimental drug targeting triple-negative breast cancer overwhelms cancer cells with toxic fats, according to new tests ...
Medically integrated dispensing improves affordability, adherence, and toxicity management via embedded pharmacy teams, ...
The free lodging, meals, and support Duane received as a guest at Hope Lodge Baltimore made it possible for him to take part ...
Oregon Health & Science University researchers have developed a first-of-its-kind method to predict cancer patient survival ...
A new study suggests that a urine-based biomarker test shows promise in forecasting bladder cancer treatment response, which ...
At AACR, Guardant Health and a Japanese group showcased data on machine learning models that predict the tissue of origin in cancers of unknown primary.
Enzymes called proteases act like molecular scissors for proteins in the body and play a role in therapies to stop viruses ...
A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types ...
Biomarkers are redefining how oncology trials are designed, shifting from single-mutation targeting to comprehensive genomic ...
Accurate detection of PIK3CA mutations is essential for personalizing breast cancer treatment, particularly with ...
Technion researchers part of international study that validates fast, accessible alternative to genomic tests using routine ...
SV-based ctDNA Monitoring in Metastatic Breast Cancer (mBC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results